CYCLODX: Out of Specification Test Results
Last updated
Summary
Product
CYCLODX
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| CYCLODX | CYCLODX | DIN 02462958 | Solution | FLUDEOXYGLUCOSE 18F 7.4 GBQ / ML | FDG251031-02 |
Issue
The target irradiation time for the production of the active ingredient Fludeoxyglucose 18F is out of specification for the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Health Care Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs - Radiopharmaceuticals
Companies
CIUSS DE L'ESTRIE - CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE
3001, 12eme Avenue Nord
Sherbrooke, Quebec
Canada
J1H 5N4
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Recall date
Identification number
RA-78455
Get notified
Receive emails about new and updated recall and safety alerts.